MA
Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui
About Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui
Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui has 12 years in corporate governance. Holds Additional Director and Director roles. Currently with 1 company, including Schwall Pharma Private Limited and Medi Schwall Pharma Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Medi Schwall Pharma Private Limited
U24304MH2019PTC329435
|
Director | 19 Aug 2019 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Schwall Pharma Private Limited
U24233MH2013PTC240600
|
Additional Director | 27 Sep 2013 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui
Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui has 12 years in corporate governance. Holds Additional Director and Director roles. Currently with 1 company, including Schwall Pharma Private Limited and Medi Schwall Pharma Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.
Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui is associated with 1 company as Additional Director and Director.
Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui has expertise in General Business.
Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui has 12 years in corporate governance.